Fennec Pharmaceuticals
FENC
#7954
Rank
HK$3.31 B
Marketcap
HK$94.41
Share price
-3.29%
Change (1 day)
N/A
Change (1 year)

Earnings for Fennec Pharmaceuticals (FENC)

Earnings in 2026 (TTM): -HK$24.01 Million

According to Fennec Pharmaceuticals's latest financial reports the company's current earnings are HK$59.22 Million. In 2025 the company made an earning of -HK$75.57 Million a decrease over its 2024 earnings that were of -HK$0.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fennec Pharmaceuticals from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$24.01 Million-68.23%
2025 -HK$75.57 Million13471.83%
2024 -HK$0.56 Million-99.56%
2023 -HK$0.13 Billion-32.34%
2022 -HK$0.19 Billion36.71%
2021 -HK$0.14 Billion-4.21%
2020 -HK$0.15 Billion41.75%
2019 -HK$0.11 Billion29.2%
2018 -HK$77.54 Million40.33%
2017 -HK$55.26 Million152.64%
2016 -HK$21.88 Million323.22%
2015 -HK$5.17 Million-69.72%
2014 -HK$17.07 Million-218%
2013 HK$14.45 M-240.02%
2012 -HK$10.33 Million-128.1%
2011 HK$36.74 M-327.81%
2010 -HK$16.14 Million-19.77%
2009 -HK$20.11 Million-81.44%
2008 -HK$0.11 Billion-0.81%
2007 -HK$0.11 Billion-30.68%
2006 -HK$0.16 Billion-6.69%
2005 -HK$0.17 Billion
2003 -HK$67.15 Million82.16%
2002 -HK$36.87 Million9.38%
2001 -HK$33.7 Million